ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026
Initial experience utilizing the right internal jugular vein access for implantation of retrievable leadless pacemakers: safety, efficacy, and efficiency.
Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough leadless pacemakers are traditionally implanted utilizing femoral venous access, the right internal jugular vein is an alternative site that may be preferable for patients with complex vasculature or contraindications to femoral access. The purpose of this study is to evaluate the safety, feasibility, and procedural efficiency of the AVEIR VR leadless pacemaker implantation via the right internal jugular venous access compared to traditional right femoral venous access in adult patients.
methodsThis is a retrospective, single-center study of all adult patients who received an AVEIR VR device at our facility. Patients were stratified by venous access site (right femoral vein or right internal jugular vein), and patient outcomes were collected from device implant until the 3-month follow-up visit. Comparison between groups was performed using the intention-to-treat protocol.
resultsA total of 56 patients (24 right femoral, 32 right internal jugular) were included in this study. Baseline characteristics were shown to be equivalent between the groups. There was no significant difference in adverse events or pacemaker metrics (device threshold, sensing, impedance) between the two groups.
conclusionRight internal jugular venous access is a feasible and safe alternative to femoral access for AVEIR VR implantation. With proper operator and anesthetist experience, procedural outcomes and device performance are comparable to those achieved with the standard femoral approach.
Indexed as
Identifiers
41099983What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.